PURPOSE OF REVIEW: The number one cause of @entity204 in the United States and in most countries around the world is @entity65 . The number one or two cause of @entity204 in @entity263 @entity1 is also @entity65 . These observations do not serve to belittle the impact of @entity263 , but serve as a reminder that the ultimate goal of dietary supplement recommendations is to reduce the burden of both of these major causes of @entity204 , especially after definitive prostate therapy. Several supplements should be discussed with a @entity1 following definitive @entity263 therapy. RECENT FINDINGS: On the basis of observational studies, a general cheap multivitamin that provides the recommended daily values of @entity1501 , B6, B12 and @entity560 may reduce the risk of a variety of @entity102 . @entity4259 supplements at 200 microg/day should be reserved only for @entity1 with a deficient level of plasma @entity4259 , but healthy dietary sources should be recommended for most @entity1 . Low-dose @entity270 supplements may be adequate for current or recent smokers but not non-smokers. All @entity1 should be encouraged to consume healthy dietary sources of @entity270 , regardless of smoking status. Low-dose daily @entity117 may be the best over the counter product to utilize as a preventive agent; this statement is made on the basis of the numerous clinical studies that support its use for individuals that qualify after consulting with their physician or a specialist to evaluate current @entity65 . In addition, fish oil supplements have gained acceptance as a possible therapy in high-risk cardiovascular @entity1 . SUMMARY: The potential future role in @entity263 should be of interest, and preliminary data is noteworthy. Regardless, all of these supplements have indirect evidence for effects in @entity263 , but it seems that only a minority of @entity1 overall qualify for them currently, with the exception of a low-dose @entity117 or multivitamin.

The use of complementary/preventive medicine to prevent XXXX recurrence/progression following definitive therapy. Part II--rapid review of dietary supplements.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'men'] @entity1501 :: ('MESH:D005492', 'Chemical') :: ['folic acid'] @entity263 :: ('MESH:D011471', 'Disease') :: ['prostate cancer'] @entity270 :: ('MESH:D014810', 'Chemical') :: ['vitamin E'] @entity4259 :: ('MESH:D012643', 'Chemical') :: ['Selenium', 'selenium'] @entity117 :: ('MESH:D001241', 'Chemical') :: ['aspirin'] @entity102 :: ('MESH:D002908', 'Disease') :: ['chronic diseases'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death'] @entity65 :: ('MESH:D002318', 'Disease') :: ['cardiovascular disease', 'cardiovascular risk'] @entity560 :: ('MESH:D014807', 'Chemical') :: ['vitamin D']
@entity263 :: (MESH:D011471,Disease) :: ['prostate cancer']
